文献速递临床试验与 GCP新药、器械与细胞基因治疗研发

脂质体布比卡因与盐酸布比卡因竖脊肌平面阻滞在心脏手术中的实用随机对照试验方案

Liposomal bupivacaine versus bupivacaine hydrochloride erector spinae plane blocks in cardiac surgery: protocol for a pragmatic randomized controlled trial.
PubMed 文献 · Trials · 2026-04-02

该实用随机对照试验方案拟在心脏手术患者中比较脂质体布比卡因与盐酸布比卡因竖脊肌平面阻滞对术后阿片类药物消耗的影响。计划同意150例受试者以获取96例可评估受试者,分为微创开胸和正中开胸两组,主要结局为术后阿片类药物消耗量(吗啡当量)。

要点

  • 心脏手术后多模式镇痛中竖脊肌平面阻滞的应用日益增多,但缺乏前瞻性数据指导局部麻醉药选择。
  • 该试验主要比较脂质体布比卡因与盐酸布比卡因对术后阿片类药物消耗的影响。
  • 试验采用双盲设计,并采取措施对电子病历和药物准备进行设盲。

核心结论

  • 该试验旨在确定脂质体布比卡因相对于盐酸布比卡因在减少心脏手术后阿片类药物消耗及其他临床结局方面的获益。

研究设计与样本

  • 实用随机对照试验方案,计划同意150例受试者以获取96例可评估受试者。
  • 受试者接受微创开胸(脂质体布比卡因N=24,盐酸布比卡因N=24)或正中开胸(脂质体布比卡因N=24,盐酸布比卡因N=24)。
  • 双盲设计,对电子病历和药物准备采取设盲措施。
  • 试验在美国东北部单中心学术医疗中心进行,目前正在招募受试者。

关键数值与推荐

  • 主要结局为术后阿片类药物消耗量,以吗啡当量报告。
  • 次要结局包括术后非阿片类镇痛药消耗、住院和门诊术后疼痛评分、30天死亡率和主要发病率、术后生活质量及住院费用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Postoperative pain management after cardiac surgery involves a multimodal approach. Recently, the erector spinae plane (ESP) block has been incorporated into multimodal pain control protocols. These measures have been taken to increase patient satisfaction while minimizing opioid usage. Prospective data is lacking to guide decisions regarding optimal regional anesthetic agents. This randomized controlled pragmatic trial protocol seeks to determine the benefit of liposomal bupivacaine relative to plain bupivacaine hydrochloride at reducing postoperative opioid consumption and other clinical outcomes following cardiac surgery. METHODS: The investigators anticipate consenting 150 subjects to obtain 96 evaluable subjects undergoing minithoracotomy (N = 24 liposomal bupivacaine, N = 24 bupivacaine hydrochloride) or open sternotomy (N = 24 liposomal bupivacaine, N = 24 bupivacaine hydrochloride). The primary outcome will be postoperative opioid consumption, reported in morphine equivalents. Secondary outcomes will include postoperative nonopioid analgesic consumption, inpatient and outpatient postoperative pain scores, 30-day mortality and major morbidity rates, postoperative quality of life, and hospitalization costs. Double blinding will be conducted with necessary measures taken to mask electronic medical records and drug preparation. DISCUSSION: The trial is currently enrolling subjects at a single academic medical center in the northeastern United States. The current study aims to investigate the postoperative pain reported by patients undergoing cardiac surgery when receiving ESP blocks with liposomal bupivacaine (experimental) compared to its hydrochloride formulation (control). TRIAL REGISTRATION: ClinicalTrials.gov NCT06077422. Registered on October 2023. https://clinicaltrials.gov/study/NCT06077422?tab=table .

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Yoo J, Pepe RJ, Nithikasem S, et al. Liposomal bupivacaine versus bupivacaine hydrochloride erector spinae plane blocks in cardiac surgery: protocol for a pragmatic randomized controlled trial. Trials. 2026. PMID: 41923260. doi:10.1186/s13063-026-09620-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。